Dr. Salvador Lanza, MD
47% Complete
Profile completeness
ZIP Healthcare Access Score
Moderate Access
ZIP 32806 • C
21+
Years in Practice
Healthcare Access Where Dr. Salvador Lanza Practices
ZIP code 32806 • Orlando, Florida
Some healthcare services require significant travel or wait times in ZIP 32806.
View full Healthcare Access Score report for ZIP 32806Conditions Dr. Salvador Lanza Can Help With
Based on specialty, these are the relevant healthcare access scores for the practice area
Practice Locations
3 locations
About Dr. Salvador Lanza
Salvador Lanza, MD is a healthcare provider with 21 years of experience.
Specialty Definition
An internist who specializes in diseases of the heart and blood vessels and manages complex cardiac conditions such as heart attacks and life-threatening, abnormal heartbeat rhythms.
43
Years Experience
3
Locations
2
States Licensed
Credentials & Board Certifications
Additional Specialties
Credentials verified via NPI Registry (NPPES)
Education & Training
Medical School
University Of Miami, Lm Miller School Of Medicine
Class of 1983
Licenses & Practice States
Licensed in 2 states
| State | License | Classification | Primary |
|---|---|---|---|
| Massachusetts | 238293 | Internal Medicine | — |
| Florida | ME53222 | Internal Medicine |
Public Data Summary for Dr. Salvador Lanza
With 21 years of practice, Dr. Salvador Lanza is an established healthcare provider, MD, after earning their medical degree at University Of Miami, Lm Miller School Of Medicine in 1983. Dr. currently practices across 3 facilities, including Ophthalmic Partners Of Florida Pa in Orlando, Florida. Their National Provider Identifier (NPI) is 1801893441, and the profile below combines data from CMS NPPES, Medicare billing records, the HHS OIG exclusion list, and — where available — CMS Open Payments, Medicare Utilization, and Part D prescriber summaries.
Dr. Salvador Lanza's practice is located in ZIP 32806 (Orlando, Florida), which has an overall CartoChrome Healthcare Access Score of 59/100 (Moderate Access). Access to care in this area is moderate — most services are reachable but with meaningful variability by specialty.
CMS Medicare data shows Dr. Salvador Lanza as a moderate-volume healthcare provider, treating approximately 982 Medicare beneficiaries and delivering 3K services in the most recent reporting year. That panel size indicates balanced experience across typical Medicare conditions.
Under the Physician Payments Sunshine Act, CMS reports that Dr. Salvador Lanza received $464 in industry payments in 2023. Payments at this scale are typical for most practicing physicians and generally reflect routine educational activities.
Transparency & Safety
Public records from CMS and OIG databases
Industry Payments
$464
Total payments received from pharmaceutical and medical device companies in 2023.
Source: CMS Open Payments (Sunshine Act)
Opioid Prescribing
This provider has no opioid prescriptions on file in Medicare Part D data.
Insurance & Accessibility
Reviews
Community reviews for Dr. Salvador Lanza
--
0 reviews
FAQ
Frequently asked questions about Dr. Salvador Lanza
Where does Dr. Salvador Lanza practice?
Dr. Salvador Lanza practices at Ophthalmic Partners Of Florida Pa in Orlando, Florida. Dr. is also affiliated with 2 additional facilities, listed below.
Does Dr. Salvador Lanza accept Medicare?
Based on CMS records, Dr. Salvador Lanza has not filed a Medicare opt-out affidavit, which means they typically accept Medicare-covered patients. CMS billing data shows 982 Medicare beneficiaries treated in the most recent reporting year.
What is Dr. Salvador Lanza's NPI number?
Dr. Salvador Lanza's National Provider Identifier (NPI) is 1801893441. This is the unique 10-digit number the Centers for Medicare & Medicaid Services assigns to every practicing US healthcare provider. You can verify this number directly at the NPPES NPI Registry.
How long has Dr. Salvador Lanza been practicing?
Dr. Salvador Lanza has approximately 21 years of practice experience, having graduated from University Of Miami, Lm Miller School Of Medicine in 1983.